ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alfuzosin Hydrochloride Sustained Release Tablets Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-0F17073
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Alfuzosin Hydrochloride Sustained Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Alfuzosin Hydrochloride Sustained Release Tablets Market Research Report 2024

Code: QYRE-Auto-0F17073
Report
March 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Apotex
TEVA
Mylan NV
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
WOCKHARDT
Unichem Laboratories
Sanofi
Lunanbet Pharmaceutical
CSPC Pharmaceutical Group

Alfuzosin Hydrochloride Sustained Release Tablets Market

Alfuzosin hydrochloride is used to treat high blood pressure and treat certain functional symptoms of benign prostatic hyperplasia.
The global Alfuzosin Hydrochloride Sustained Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alfuzosin Hydrochloride Sustained Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alfuzosin Hydrochloride Sustained Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets include Mylan, Teva, Apotex, Torrent Pharmaceuticals, Sun Pharma, Aurobindo, Wockhardt, Unichem Laboratories and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alfuzosin Hydrochloride Sustained Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alfuzosin Hydrochloride Sustained Release Tablets.

Report Scope

The Alfuzosin Hydrochloride Sustained Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alfuzosin Hydrochloride Sustained Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alfuzosin Hydrochloride Sustained Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Alfuzosin Hydrochloride Sustained Release Tablets Market Report

Report Metric Details
Report Name Alfuzosin Hydrochloride Sustained Release Tablets Market
Segment by Type
  • 2.5mg
  • 5mg
  • 10mg
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan, Teva, Apotex, Torrent Pharmaceuticals, Sun Pharma, Aurobindo, Wockhardt, Unichem Laboratories, Sanofi, Lunanbet Pharmaceutical, CSPC Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alfuzosin Hydrochloride Sustained Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alfuzosin Hydrochloride Sustained Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alfuzosin Hydrochloride Sustained Release Tablets Market report?

Ans: The main players in the Alfuzosin Hydrochloride Sustained Release Tablets Market are Mylan, Teva, Apotex, Torrent Pharmaceuticals, Sun Pharma, Aurobindo, Wockhardt, Unichem Laboratories, Sanofi, Lunanbet Pharmaceutical, CSPC Pharmaceutical Group

What are the Application segmentation covered in the Alfuzosin Hydrochloride Sustained Release Tablets Market report?

Ans: The Applications covered in the Alfuzosin Hydrochloride Sustained Release Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Alfuzosin Hydrochloride Sustained Release Tablets Market report?

Ans: The Types covered in the Alfuzosin Hydrochloride Sustained Release Tablets Market report are 2.5mg, 5mg, 10mg

1 Alfuzosin Hydrochloride Sustained Release Tablets Market Overview
1.1 Product Overview and Scope of Alfuzosin Hydrochloride Sustained Release Tablets
1.2 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Type
1.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value Comparison by Type (2024-2030)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.3 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Application
1.3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2019-2030
1.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales 2019-2030
1.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alfuzosin Hydrochloride Sustained Release Tablets Market Competition by Manufacturers
2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Alfuzosin Hydrochloride Sustained Release Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, Product Type & Application
2.7 Alfuzosin Hydrochloride Sustained Release Tablets Market Competitive Situation and Trends
2.7.1 Alfuzosin Hydrochloride Sustained Release Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alfuzosin Hydrochloride Sustained Release Tablets Players Market Share by Revenue
2.7.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alfuzosin Hydrochloride Sustained Release Tablets Retrospective Market Scenario by Region
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region: 2019-2030
3.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region: 2019-2024
3.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region: 2025-2030
3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region: 2019-2030
3.3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region: 2019-2024
3.3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region: 2025-2030
3.4 North America Alfuzosin Hydrochloride Sustained Release Tablets Market Facts & Figures by Country
3.4.1 North America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2030)
3.4.3 North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alfuzosin Hydrochloride Sustained Release Tablets Market Facts & Figures by Country
3.5.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2030)
3.5.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Alfuzosin Hydrochloride Sustained Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2030)
3.7.3 Latin America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2019-2030)
4.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2019-2024)
4.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2025-2030)
4.1.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2019-2030)
4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2019-2030)
4.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2019-2024)
4.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2025-2030)
4.2.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2019-2030)
5.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2019-2024)
5.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2025-2030)
5.1.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2019-2030)
5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2019-2030)
5.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2019-2024)
5.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2025-2030)
5.2.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Corporation Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Torrent Pharmaceuticals
6.4.1 Torrent Pharmaceuticals Corporation Information
6.4.2 Torrent Pharmaceuticals Description and Business Overview
6.4.3 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.4.5 Torrent Pharmaceuticals Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.7.5 Wockhardt Recent Developments/Updates
6.8 Unichem Laboratories
6.8.1 Unichem Laboratories Corporation Information
6.8.2 Unichem Laboratories Description and Business Overview
6.8.3 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.8.5 Unichem Laboratories Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Lunanbet Pharmaceutical
6.10.1 Lunanbet Pharmaceutical Corporation Information
6.10.2 Lunanbet Pharmaceutical Description and Business Overview
6.10.3 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.10.5 Lunanbet Pharmaceutical Recent Developments/Updates
6.11 CSPC Pharmaceutical Group
6.11.1 CSPC Pharmaceutical Group Corporation Information
6.11.2 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Description and Business Overview
6.11.3 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolio
6.11.5 CSPC Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alfuzosin Hydrochloride Sustained Release Tablets Industry Chain Analysis
7.2 Alfuzosin Hydrochloride Sustained Release Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alfuzosin Hydrochloride Sustained Release Tablets Production Mode & Process
7.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales and Marketing
7.4.1 Alfuzosin Hydrochloride Sustained Release Tablets Sales Channels
7.4.2 Alfuzosin Hydrochloride Sustained Release Tablets Distributors
7.5 Alfuzosin Hydrochloride Sustained Release Tablets Customers
8 Alfuzosin Hydrochloride Sustained Release Tablets Market Dynamics
8.1 Alfuzosin Hydrochloride Sustained Release Tablets Industry Trends
8.2 Alfuzosin Hydrochloride Sustained Release Tablets Market Drivers
8.3 Alfuzosin Hydrochloride Sustained Release Tablets Market Challenges
8.4 Alfuzosin Hydrochloride Sustained Release Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Apotex
TEVA
Mylan NV
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
WOCKHARDT
Unichem Laboratories
Sanofi
Lunanbet Pharmaceutical
CSPC Pharmaceutical Group
List of Tables
    Table 1. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Alfuzosin Hydrochloride Sustained Release Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Alfuzosin Hydrochloride Sustained Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, Product Type & Application
    Table 12. Global Key Manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Alfuzosin Hydrochloride Sustained Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alfuzosin Hydrochloride Sustained Release Tablets as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2019-2024) & (K Units)
    Table 18. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2019-2024)
    Table 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2025-2030) & (K Units)
    Table 20. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2025-2030)
    Table 21. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2019-2024)
    Table 23. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2025-2030)
    Table 25. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024) & (K Units)
    Table 27. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2025-2030) & (K Units)
    Table 28. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Type (2019-2024)
    Table 51. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Type (2025-2030)
    Table 52. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2019-2024)
    Table 53. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2025-2030)
    Table 54. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2019-2024)
    Table 57. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2025-2030)
    Table 58. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Application (2019-2024)
    Table 61. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units) by Application (2025-2030)
    Table 62. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2019-2024)
    Table 63. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2025-2030)
    Table 64. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2019-2024)
    Table 67. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2025-2030)
    Table 68. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Application (2025-2030)
    Table 70. Mylan Corporation Information
    Table 71. Mylan Description and Business Overview
    Table 72. Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Mylan Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 74. Mylan Recent Developments/Updates
    Table 75. Teva Corporation Information
    Table 76. Teva Description and Business Overview
    Table 77. Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Teva Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 79. Teva Recent Developments/Updates
    Table 80. Apotex Corporation Information
    Table 81. Apotex Description and Business Overview
    Table 82. Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Apotex Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 84. Apotex Recent Developments/Updates
    Table 85. Torrent Pharmaceuticals Corporation Information
    Table 86. Torrent Pharmaceuticals Description and Business Overview
    Table 87. Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 89. Torrent Pharmaceuticals Recent Developments/Updates
    Table 90. Sun Pharma Corporation Information
    Table 91. Sun Pharma Description and Business Overview
    Table 92. Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 94. Sun Pharma Recent Developments/Updates
    Table 95. Aurobindo Corporation Information
    Table 96. Aurobindo Description and Business Overview
    Table 97. Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 99. Aurobindo Recent Developments/Updates
    Table 100. Wockhardt Corporation Information
    Table 101. Wockhardt Description and Business Overview
    Table 102. Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 104. Wockhardt Recent Developments/Updates
    Table 105. Unichem Laboratories Corporation Information
    Table 106. Unichem Laboratories Description and Business Overview
    Table 107. Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 109. Unichem Laboratories Recent Developments/Updates
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 114. Sanofi Recent Developments/Updates
    Table 115. Lunanbet Pharmaceutical Corporation Information
    Table 116. Lunanbet Pharmaceutical Description and Business Overview
    Table 117. Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 119. Lunanbet Pharmaceutical Recent Developments/Updates
    Table 120. CSPC Pharmaceutical Group Corporation Information
    Table 121. CSPC Pharmaceutical Group Description and Business Overview
    Table 122. CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Product
    Table 124. CSPC Pharmaceutical Group Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Alfuzosin Hydrochloride Sustained Release Tablets Distributors List
    Table 128. Alfuzosin Hydrochloride Sustained Release Tablets Customers List
    Table 129. Alfuzosin Hydrochloride Sustained Release Tablets Market Trends
    Table 130. Alfuzosin Hydrochloride Sustained Release Tablets Market Drivers
    Table 131. Alfuzosin Hydrochloride Sustained Release Tablets Market Challenges
    Table 132. Alfuzosin Hydrochloride Sustained Release Tablets Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Alfuzosin Hydrochloride Sustained Release Tablets
    Figure 2. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Share by Type in 2023 & 2030
    Figure 4. 2.5mg Product Picture
    Figure 5. 5mg Product Picture
    Figure 6. 10mg Product Picture
    Figure 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Other
    Figure 12. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales (2019-2030) & (K Units)
    Figure 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price (US$/Unit) & (2019-2030)
    Figure 16. Alfuzosin Hydrochloride Sustained Release Tablets Report Years Considered
    Figure 17. Alfuzosin Hydrochloride Sustained Release Tablets Sales Share by Manufacturers in 2023
    Figure 18. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Alfuzosin Hydrochloride Sustained Release Tablets Players: Market Share by Revenue in 2023
    Figure 20. Alfuzosin Hydrochloride Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2019-2030)
    Figure 23. North America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2019-2030)
    Figure 24. United States Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2019-2030)
    Figure 27. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Netherlands Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2019-2030)
    Figure 35. China Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Alfuzosin Hydrochloride Sustained Release Tablets by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Alfuzosin Hydrochloride Sustained Release Tablets by Type (2019-2030)
    Figure 54. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Alfuzosin Hydrochloride Sustained Release Tablets by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Alfuzosin Hydrochloride Sustained Release Tablets by Application (2019-2030)
    Figure 57. Global Alfuzosin Hydrochloride Sustained Release Tablets Price (US$/Unit) by Application (2019-2030)
    Figure 58. Alfuzosin Hydrochloride Sustained Release Tablets Value Chain
    Figure 59. Alfuzosin Hydrochloride Sustained Release Tablets Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Alfuzosin Market Insights Forecast to 2030
Global Felodipine Sustained Release Tablet Market Research Report 2024
Global Diltiazem Hydrochloride Extended Release Tablets Market Research Report 2025
Global Amiloride Hydrochloride Tablets Market Research Report 2024
Global Phenoxybenzamine Hydrochloride Tablets Market Research Report 2024
Global Fosinopril Sodium Tablets Market Research Report 2024
Global Chlorothiazide Sodium Injection Market Research Report 2024
Global Verapamil Hydrochloride Tablets Market Research Report 2025
Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Global Doxazosin Mesylate Market Research Report 2024
Tamsulosin Hydrochloride Sustained Release Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tamsulosin Market Insights Forecast to 2030
Global Losartan and Hydrochlorothiazide Tablets Market Research Report 2024
Hematuria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Benign Prostate Hyperplasia Drugs Market Insights Forecast to 2030
Benign Prostatic Hyperplasia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lisinopril Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nicardipine Hydrochloride Tablets Market Research Report 2025
Global Benign Prostatic Hypertrophy Medication Market Research Report 2024
Global Alfentanil Hydrochloride API Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions